Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTR
451
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $58.2M | 0.05% |
1,145,600
+133,300
| +13% | +$6.92M |
|
|
NXRT
452
NexPoint Residential Trust
NXRT
$640M
| $58.1M | 0.05% |
1,243,500
+13,900
| +1% | +$622K |
|
453
SEI Investments
SEIC
$12.8B
| $58M | 0.05% |
979,426
-140,800
| -13% | -$8.14M |
|
454
Rambus
RMBS
$10.7B
| $57.8M | 0.05% |
4,403,200
-146,686
| -3% | -$1.84M |
|
455
Banco de Chile
BCH
$20.4B
| $57.7M | 0.05% |
2,052,475
-49,500
| -2% | -$1.43M |
|
|
AGR
456
DELISTED
Avangrid, Inc.
AGR
| $57.6M | 0.05% |
1,102,755
+136,900
| +14% | +$6.88M |
|
457
Chevron
CVX
$388B
| $57.5M | 0.05% |
+484,484
| New | +$58.8M |
|
|
MODV
458
DELISTED
ModivCare
MODV
| $57.3M | 0.05% |
963,320
+56,221
| +6% | +$3.2M |
|
459
Advanced Energy
AEIS
$13.2B
| $56.8M | 0.05% |
989,222
-272,695
| -22% | -$14.7M |
|
460
Universal Corp
UVV
$1.12B
| $56.8M | 0.05% |
1,035,410
+82,000
| +9% | +$4.6M |
|
|
MIME
461
DELISTED
Mimecast Limited
MIME
| $56.7M | 0.05% |
1,588,400
+78,400
| +5% | +$3.41M |
|
462
Valvoline
VVV
$4.31B
| $56.5M | 0.05% |
2,566,962
+2,385,862
| +1,317% | +$51.2M |
|
463
W.W. Grainger
GWW
$62.1B
| $56.5M | 0.05% |
190,200
+150,600
| +380% | +$41.9M |
|
464
Banco Santander Chile
BSAC
$16.2B
| $56.4M | 0.05% |
2,015,527
-143,000
| -7% | -$4.13M |
|
465
Builders FirstSource
BLDR
$7.93B
| $56.2M | 0.05% |
2,732,100
+963,300
| +54% | +$18M |
|
466
Flowers Foods
FLO
$1.6B
| $56.1M | 0.05% |
2,426,883
+643,101
| +36% | +$14.9M |
|
|
LOGM
467
DELISTED
LogMein, Inc.
LOGM
| $56.1M | 0.05% |
790,612
+46,473
| +6% | +$3.33M |
|
468
Dr. Reddy's Laboratories
RDY
$10.4B
| $56M | 0.05% |
7,392,410
+1,399,410
| +23% | +$10.4M |
|
469
SolarEdge
SEDG
$1.97B
| $55.8M | 0.05% |
666,500
+336,022
| +102% | +$25.1M |
|
|
STOR
470
DELISTED
STORE Capital Corporation
STOR
| $55.6M | 0.05% |
1,485,400
+521,600
| +54% | +$18.7M |
|
471
PPG Industries
PPG
$25.5B
| $55.5M | 0.05% |
468,500
+230,000
| +96% | +$26.5M |
|
472
Chefs' Warehouse
CHEF
$4.56B
| $54.7M | 0.05% |
1,356,300
+87,000
| +7% | +$3.26M |
|
|
PVTL
473
DELISTED
Pivotal Software, Inc.
PVTL
| $54.6M | 0.05% |
3,659,800
+2,703,400
| +283% | +$33.1M |
|
474
Melco Resorts & Entertainment
MLCO
$2.14B
| $54.5M | 0.05% |
2,809,300
+1,101,800
| +65% | +$23.9M |
|
475
HealthEquity
HQY
$8.82B
| $54.2M | 0.05% |
947,943
-214,291
| -18% | -$14.2M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.